Truncating erythropoietin receptor rearrangements in acute lymphoblastic leukemia Journal Article


Authors: Iacobucci, I.; Li, Y.; Roberts, K. G.; Dobson, S. M.; Kim, J. C.; Payne-Turner, D.; Harvey, R. C.; Valentine, M.; McCastlain, K.; Easton, J.; Yergeau, D.; Janke, L. J.; Shao, Y.; Chen, I. M. L.; Rusch, M.; Zandi, S.; Kornblau, S. M.; Konopleva, M.; Jabbour, E.; Paietta, E. M.; Rowe, J. M.; Pui, C. H.; Gastier-Foster, J.; Gu, Z.; Reshmi, S.; Loh, M. L.; Racevskis, J.; Tallman, M. S.; Wiernik, P. H.; Litzow, M. R.; Willman, C. L.; McPherson, J. D.; Downing, J. R.; Zhang, J.; Dick, J. E.; Hunger, S. P.; Mullighan, C. G.
Article Title: Truncating erythropoietin receptor rearrangements in acute lymphoblastic leukemia
Abstract: Chromosomal rearrangements are a hallmark of acute lymphoblastic leukemia (ALL) and are important ALL initiating events. We describe four different rearrangements of the erythropoietin receptor gene EPOR in Philadelphia chromosome-like (Ph-like) ALL. All of these rearrangements result in truncation of the cytoplasmic tail of EPOR at residues similar to those mutated in primary familial congenital polycythemia, with preservation of the proximal tyrosine essential for receptor activation and loss of distal regulatory residues. This resulted in deregulated EPOR expression, hypersensitivity to erythropoietin stimulation, and heightened JAK-STAT activation. Expression of truncated EPOR in mouse B cell progenitors induced ALL in vivo. Human leukemic cells with EPOR rearrangements were sensitive to JAK-STAT inhibition, suggesting a therapeutic option in high-risk ALL. Iacobucci et al. show that recurrent EPOR rearrangements occur exclusively in Ph-like acute lymphoblastic leukemia (ALL), resulting in the expression of C-terminal truncated EPOR mutants that have heightened JAK-STAT signaling in response to erythropoietin and confer sensitivity to JAK-STAT inhibition in cases with these rearrangements. © 2016 Elsevier Inc..
Journal Title: Cancer Cell
Volume: 29
Issue: 2
ISSN: 1535-6108
Publisher: Cell Press  
Date Published: 2016-02-08
Start Page: 186
End Page: 200
Language: English
DOI: 10.1016/j.ccell.2015.12.013
PROVIDER: scopus
PMCID: PMC4750652
PUBMED: 26859458
DOI/URL:
Notes: Article -- Export Date: 3 March 2016 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Martin Stuart Tallman
    649 Tallman